In this episode of The Diary Of A CEO with Steven Bartlett, Dr. Stasha Gominak challenges conventional wisdom about vitamin D supplementation and its connection to sleep disorders. Gominak explains that vitamin D is actually a hormone rather than a vitamin, and that deficiency disrupts REM sleep, gut microbiome health, and B vitamin production in ways that standard medical practice often overlooks. She traces many modern health epidemics—including sleep disorders, obesity, and metabolic disease—to the 1980s shift toward indoor lifestyles, sunscreen use, and reduced sun exposure.
The conversation covers Gominak's Right Sleep Protocol, which uses personalized blood testing to correct vitamin D and B vitamin deficiencies and restore healthy sleep patterns. She discusses why typical behavioral sleep interventions and pharmaceutical approaches fail to address underlying biochemical causes, and explains the critical but often misunderstood relationship between sunlight exposure, vitamin D levels, microbiome function, and restorative sleep.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Stasha Gominak emphasizes that vitamin D is actually a hormone, not a vitamin, and this mislabeling has created confusion in medical practice. The Androquin Society recognizes it as a hormone, but since the 1980s, vitamin D has been treated as an over-the-counter supplement rather than a tightly monitored hormone like [restricted term] or thyroid. Unlike proper hormone supplementation, which maintains narrow blood level ranges, vitamin D is often given in fixed doses without regard to individual levels or sun exposure.
Vitamin D receptors populate specific brain stem nuclei that control the parasympathetic and sympathetic nervous systems, sleep, and circadian rhythms. Walter Stumpf's research, referenced by Gominak, highlights vitamin D's role as the "hibernation hormone" that adapts sleep and metabolism. Additionally, vitamin D influences acetylcholine production, which is critical for sleep initiation and the parasympathetic "rest-and-digest" state. Inadequate sunlight and resulting vitamin D deficiency create acetylcholine deficiency—something medical science often overlooks.
Gominak explains that supplementing with vitamin D is not equivalent to obtaining it naturally from sunlight. When UVB rays hit the skin, they produce not just vitamin D3 but at least 15-20 other anti-inflammatory and protective compounds absent in oral supplements. Stephanie Seneff's research shows that skin-produced vitamin D is sulfated, altering its biological behavior compared to non-sulfated supplements.
Other solar wavelengths, especially infrared, are also vital—they penetrate the body, energize mitochondria, and boost cellular health. Even indirect sunlight or incandescent bulbs provide health-promoting wavelengths missing from LED lighting and modern indoor environments. The increased use of LED bulbs means people are getting less infrared energy indoors, compounding the loss from spending more time inside.
Gominak observes that vitamin D levels below 30 ng/ml consistently appear in patients with sleep disorders and neurological problems. She describes deficiency as causing the brain to "forget how to sleep," disrupting REM sleep regulation. A hallmark symptom is waking at 3 a.m. and being unable to fall back asleep, or experiencing lighter sleep, headaches, or cognitive impairment after 3 a.m.
Long-term vitamin D deficiency impairs REM sleep, leading to mood disturbances, memory problems, and neurochemical issues. This creates higher risk for depression and cognitive decline. Maintaining vitamin D levels above 60 ng/ml is often crucial for resolving persistent sleep and medical issues when regular sun exposure isn't possible.
Dr. Gominak details the intricate relationship between vitamin D deficiency, B vitamin depletion, and gut microbiome dysfunction, highlighting how these interconnected systems impact sleep, immunity, pain, and inflammation.
Gominak explains that the human gut microbiome produces all eight essential B vitamins as growth factors through microbial processes, not primarily through diet. Humans rely on this relationship: providing vitamin D for bacteria, which in return supply B vitamins vital for human nutrition. Vitamin D deficiency alters microbiome composition, leading to pathogenic organisms and collapse of the vitamin-producing bacterial ecosystem. This dysfunction reduces B vitamin supply even with adequate dietary intake. Gominak attributes the emergence of conditions like IBS in the 1980s partly to widespread vitamin D deficiency disrupting healthy microbiome populations.
Administering vitamin D alone stimulates tissue repair and growth, increasing demand for B vitamins when the disrupted microbiome cannot keep up production. Many patients who began taking vitamin D during COVID developed symptoms like burning sensations in hands and feet after several years—signs of pantothenic acid (B5) deficiency. This pattern suggests vitamin D therapy accelerates B vitamin consumption for cellular repair, but without a restored microbiome to provide adequate supply, deficiency states follow.
Correction requires both vitamin D and B-complex supplementation to reestablish a healthy microbiome capable of endogenous B vitamin production. Gominak prescribes vitamin D and B50 or B100 complexes together for approximately three months, supplying required growth factors for beneficial bacteria. Once restored, the microbiome resumes natural B vitamin production, eliminating the need for ongoing supplementation. She cautions that continued supplementation beyond this repair phase is unnecessary and potentially counterproductive—large B vitamin doses after full restoration may cause adverse symptoms like pain or sleep disruption.
Gominak draws a direct link between sleep quality and microbiome status. Poor sleep disrupts circadian signaling within the microbiome, affecting bacterial reproduction and B vitamin production. This creates a feedback loop: degraded sleep diminishes microbiome integrity, further lowering B vitamin synthesis and making restorative sleep harder to achieve. Through this lens, conditions presenting as sleep or pain disorders are often symptoms of underlying vitamin D deficiency, depleted microbial B vitamin supply, and a disrupted feedback system between sleep and gut health.
Modern society's shift indoors—with adoption of sunscreen, air conditioning, and digital devices—has fueled an epidemic of sleep disorders, obesity, metabolic disease, and vitamin D deficiency. Stasha Gominak and Steven Bartlett discuss how these changes fundamentally disrupt evolutionary sleep biology.
Gominak describes growing up before the 1980s, when only two kids in her class of 300 were overweight, and depression and attention disorders were uncommon. She and Bartlett explain that sunscreen, air conditioning, and computers all became common in the 1980s, driving people indoors. Sunscreen, introduced widely around 1985, blocks vitamin D synthesis. Over decades, recommendations to prevent sunburn morphed into a broad mandate to avoid sun altogether. Gominak points out that beginning in the mid-1980s, diseases like type 2 diabetes, non-alcoholic fatty liver disease, ADHD, and depression quickly rose—all coincident with changes in sun exposure and indoor lifestyles.
Humans are biologically designed for outdoor living, with regular sunlight exposure critical for metabolic health, hormone production, and restorative sleep. Gominak notes that wild animals remain lean and healthy, while only indoor-confined animals like cats and dogs grow overweight. She observes that in rural Mexico, elderly people living outdoors into their 80s and 90s show no signs of obesity, lethargy, or sleep problems typical of indoor populations. This proves age alone isn't the major factor in metabolic and sleep decline—rather, it's lack of sunlight and outdoor activity.
Gominak emphasizes that human sleep-wake cycles, hormone regulation, and neurological functions evolved in response to predictable outdoor sun patterns. Bartlett explains that sunlight's intense brightness resets the brain's master clock and suppresses daytime melatonin. Present-day indoor living cannot recreate these essential biological cues, leading people to fall asleep at 4 a.m. and wake at noon, out of sync with societal demands.
Gominak notes that COVID-19 lockdowns intensified these problems by forcing populations indoors, amplifying vitamin D deficiency and sleep disturbances. Bartlett points to an acute spike in such disorders following lockdowns, providing a living demonstration of sunlight deprivation's dangers. After lockdowns, cases of sleep disorders and metabolic disease increased alongside reports of vitamin D deficiency, further tying extensive indoor confinement to these epidemics.
With an emphasis on preventing sunburn, public health advice steered people away from the sun without accounting for vitamin D's essential role. Gominak clarifies that direct sun exposure is necessary for vitamin D synthesis, and windows block the needed UVB rays. Over decades, balanced sunscreen advice became an outright ban on sun exposure. Bartlett cites data showing 90% of Americans spend approximately 22 hours indoors each day, and 20% never go outdoors. This mass indoor lifestyle starves people of critical sunlight, perpetuating the sleep epidemic, metabolic decline, and vitamin D deficiency crisis.
The Right Sleep Protocol is an individualized program using blood-based biochemistry to identify and correct vitamin D and B deficiencies to restore healthy sleep. Dr. Gominak emphasizes that effectiveness relies on personalizing supplementation according to precise blood levels and tracking responses.
The protocol begins with baseline blood tests for vitamin D and B12. Gominak notes that vitamin D must be dosed based on measured blood levels, targeting concentrations between 60-100 nanograms per milliliter. Dosages are adjusted monthly based on blood levels, recognizing that requirements vary widely—from 10,000 up to 30,000 IUs daily for some individuals.
The protocol phases include vitamin D foundation, B12 supplementation if deficient, B-complex for 3-4 months, then multivitamin maintenance. After three months, a B-complex supplement is introduced if indicated. Once sleep improves, patients wean off high-dose B vitamins and transition to a multivitamin, staging the return of nutrients provided by the healthy microbiome.
Clinical experience revealed that while vitamin D often improved sleep initially, patients sometimes developed new symptoms attributable to B vitamin deficiency after extended use. Adding a B-complex resolved these symptoms and further improved sleep quality, confirming the essential role of B vitamins alongside vitamin D.
After three to four months, high-dose B-complex should be discontinued as elevated blood levels suppress the microbiome's B vitamin production. Excess supplementation risks symptoms like agitation and insomnia. After stopping B-complex, a balanced multivitamin offers minimal B vitamin support while the restored microbiome resumes natural synthesis.
The protocol's goal is reestablishing a natural state where healthy sleep is maintained through adequate sun exposure, diverse diet, and robust microbiome—the physiological baseline for most of human history. Given modern lifestyles with low sunlight exposure, some individuals will still require vitamin D supplementation. Ultimately, the protocol seeks to restore the body's natural sleep mechanisms.
Because there's significant individual variation in supplement needs and responses, patients are advised to journal daily, documenting sleep quality and symptom changes. These records offer objective benchmarks to guide adjustments. The emergence of new symptoms may mean the protocol needs modification—extending a phase, adjusting a dose, or switching supplements. Written records become essential in assessing progress and recognizing regressions.
Current approaches in sleep medicine focus on environmental and behavioral interventions like blackout curtains and strict bedtimes. Gominak observes that these recommendations assume sleep disorders are psychological or stimulus-related, but they prove ineffective for individuals with underlying biochemical imbalances. She explains that when the brain is deficient in vital nutrients like vitamin D, it "forgets how to sleep." For these patients, traditional behavioral solutions cannot compensate for specific biochemical deficits—a specialized treatment rooted in brain chemistry is needed instead.
Sleep studies commonly focus on diagnosing sleep apnea, managed by pulmonologists. However, Gominak's experience shows many patients, especially women with chronic headaches and fragmented sleep, don't meet sleep apnea criteria despite severe sleep disturbances. These patients often experience abnormal or absent REM sleep, which isn't classified as sleep apnea by conventional standards, leaving them without proper diagnosis or treatment.
The dominant pharmaceutical approach centers on symptom management rather than addressing core deficiencies. Antidepressants and sleeping pills induce unconsciousness but don't restore normal REM sleep or maintain parasympathetic dominance—both critical for true restorative sleep. While such medications may increase total sleep time, patients frequently remain fatigued and continue to have cognitive decline and pain.
Gominak points out that resistance to pursuing vitamin D and microbiome research in sleep medicine reflects broader medical conservatism. She highlights that organizations like the Endocrine Society advise against routinely measuring vitamin D levels or recommending individualized supplementation, citing research gaps as justification. This adherence to existing dogma inhibits recognition of contradictory observations and hinders adoption of more effective, biochemically-informed treatments, leaving countless patients without appropriate care.
1-Page Summary
Stasha Gominak emphasizes that vitamin D is actually a hormone, not a vitamin, and this mislabeling has resulted in confusion in medicine and public health guidelines. The Androquin Society, known for their expertise in hormones, recognizes D as a hormone. Gominak explains that vitamin D, produced endogenously in the skin, was mistakenly categorized as a vitamin. As a result, since the early 1980s, vitamin D was delegated to over-the-counter "vitamin" status and regarded as less essential than tightly monitored hormones like [restricted term], estrogen, or thyroid hormones. This has led to a political fight within medical literature and an underestimation of vitamin D's significance for health.
She points out that unlike other hormones, vitamin D supplementation is usually given as a fixed dose regardless of individual levels, time of year, or sun exposure. Proper hormone supplementation in medicine is based on maintaining a narrow band of blood levels, as is done for [restricted term] or thyroid, whereas vitamin D is treated differently, often with little attention to individual blood levels.
Vitamin D receptors are present in specific nuclei of the brain stem, known as the control center for the parasympathetic and sympathetic nervous systems, as well as sleep and circadian rhythms. These brain stem areas, including those that paralyze us during REM sleep and control our sleep-wake "clock," are densely populated with vitamin D receptors. Walter Stumpf’s research—referenced by Gominak—highlights vitamin D’s central role in these processes, dubbing it the "hibernation hormone" that allows the body to adapt sleep and metabolism.
Furthermore, vitamin D influences acetylcholine production by activating the enzyme choline acetyltransferase. Acetylcholine is critical for sleep initiation and maintaining the parasympathetic "rest-and-digest" state. Inadequate sunlight and consequent vitamin D deficiency can therefore create a chemical deficiency of acetylcholine—something medical science often overlooks because there are no drugs to replace this neurotransmitter directly.
The action of vitamin D, like all hormones, involves entering the cell nucleus and modulating DNA to increase production of necessary proteins—in the brain stem, this means upregulating choline acetyltransferase to boost acetylcholine synthesis. All key autonomic nervous system functions—heart rate, blood pressure, digestion, and sleep initiation—are therefore influenced by an adequate vitamin D hormone state.
According to Gominak, supplementing with vitamin D is not equivalent to obtaining vitamin D naturally from sunlight. Our bodies absorb vitamin D through the skin when exposed to UVB rays, which convert cholesterol to D3. However, being outdoors in sunlight initiates production of not just vitamin D3 but many other anti-inflammatory and protective compounds—at least 15–20 other chemicals that are not present in oral supplements. These compounds contribute to reduced inflammation and skin health, and only develop when UVB light interacts with skin.
Stephanie Seneff’s research indicates another key difference: vitamin D formed in the skin is sulfated, altering its biological behavior in the body compared to non-sulfated supplemental D3 tablets or capsules.
Exposure to other solar wavelengths, especially infrared, is also vital for health, as infrared penetrates the body, energizes mitochondria, and boosts cellular health—something both direct and indirect sunlight provide but vitamin D pills and LED l ...
Vitamin D: Hormone, Sleep, and Brain Function
Dr. Stasha Gominak details the intricate relationship between vitamin D deficiency, B vitamin depletion, and dysfunction of the gut microbiome, highlighting how these interconnected systems impact health, particularly sleep, immunity, pain, and inflammation.
Dr. Gominak explains that the human gut microbiome—comprising four main bacterial groups—produces all eight essential B vitamins as growth factors, not primarily via diet but through microbial processes. Bacteria manufacture B vitamins and push them into their environment, sharing these compounds with neighboring microbes in a mutualistic relationship. Humans rely on this commensal connection: providing vitamin D for the bacteria, which in return supply B vitamins vital for human nutrition and cellular processes.
Vitamin D deficiency alters the composition of the microbiome, leading to a shift toward pathogenic organisms and collapse of the vitamin-producing bacterial ecosystem. This dysfunction reduces the body’s supply of B vitamins, even in the presence of adequate dietary intake. Dr. Gominak attributes the emergence of conditions like irritable bowel syndrome (IBS) in the 1980s in part to widespread vitamin D deficiency, which disrupts healthy microbiome populations. Research shows that supplementation with vitamin D can alter stool bacteria, further substantiating a direct connection between D status and gut health.
Administering vitamin D alone stimulates repair and growth in the body’s tissues, further increasing the demand for B vitamins, especially when the disrupted microbiome cannot keep up production. Many patients, as seen during the COVID pandemic, began taking vitamin D and, after several years, developed symptoms such as burning sensations in the hands and feet—a sign of pantothenic acid (B5) deficiency. Other symptoms include joint pain and sleep disturbances. This pattern persisted even after discontinuing vitamin D, suggesting that vitamin D therapy accelerates B vitamin consumption for ongoing cellular repair, but without a restored microbiome to provide an adequate supply, deficiency states follow.
Chronic vitamin D supplementation thus risks unmasking or worsening B vitamin deficiencies. Symptoms like burning in the hands and feet, headaches, and unexplained joint pain have been frequently reported among long-term vitamin D users—a clinical pattern Gominak links back to impaired gut B vitamin synthesis.
Correction of this cycle requires not only vitamin D but also B-complex supplementation to reestablish a healthy microbiome capable of endogenous B vitamin production. Dr. Gominak prescribes both vitamin D and B50 or B100 complexes (including all eight B vitamins) together for approximately three months. This combined protocol supplies the required growth factors for beneficial bacteria, enabling them to reoccupy the gut and restore mutualistic B vitamin supply.
Once restored, the microbiome resumes natural B vitamin production, gradually eliminating the need for ongoing supplementation. Gominak emphasizes that continued supplementation beyond this repair phase is unnecessary and potentially counterproductive; large doses of B vitamins after full microbiome restoration may themselves cause adverse symptoms such as pain or sleep disruption. She cautions that B vitamins, with the exception of B12, are meant to be delivered collectively and in concert with vitamin D, not separately or indefinite ...
Vitamin D Deficiency, b Vitamin Depletion, and Microbiome Dysfunction Connection
Modern society’s shift indoors—with the adoption of sunscreen, air conditioning, and digital devices—has fueled an epidemic of sleep disorders, obesity, metabolic disease, and vitamin D deficiency, replacing outdoor living that shaped human biology for over 300,000 years. Speakers Stasha Gominak and Steven Bartlett discuss how these changes fundamentally disrupt our evolutionary sleep biology and broader health.
Stasha Gominak describes growing up before the 1980s, noting that only two kids in her class of 300 were overweight, nobody needed special diets, and sleep and depression issues were rare. Antidepressants and widespread sleep problems in children did not exist, highlighting the dramatic shift in physical and mental health over the last forty years.
Gominak and Bartlett explain that sunscreen, air conditioning, and computers all became common in the 1980s, driving people indoors and away from sunlight. Sunscreen, introduced widely around 1985, blocks the body's ability to synthesize vitamin D from sunlight. Over decades, the recommendations to prevent sunburn morphed into a broad societal mandate to avoid the sun altogether, with many people believing any sun exposure is dangerous.
Gominak points out that beginning in the mid-1980s, the incidence of diseases such as type 2 diabetes, non-alcoholic fatty liver disease, ADHD, and depression quickly rose. She notes that non-alcoholic fatty liver was first described in this era, as well as an uptick in autoimmune diseases—all coincident with changes in sun exposure and indoor lifestyles, rather than solely toxins, pesticides, or diet as previously suspected.
Humans are biologically designed for outdoor living, with regular sunlight exposure critical for metabolic health, hormone production, and restorative sleep.
Gominak notes, "There are no obese squirrels in my backyard." Only animals confined indoors—such as cats and dogs—grow overweight, whereas wild animals remain lean and metabolically healthy. This pattern underscores that indoor confinement disrupts natural metabolic regulation for all species, including humans.
Gominak observes that in rural Mexico, elderly people living in stick-and-thatch structures and working outdoors into their 80s and 90s show no signs of obesity, lethargy, or sleep problems typical of indoor populations. She asserts this proves age alone is not the major factor in metabolic and sleep decline but rather a lack of sunlight and outdoor activity.
Gominak emphasizes that human sleep-wake cycles, hormone regulation, and neurological functions evolved in response to predictable outdoor sun patterns. Bartlett explains that sunlight's intense brightness resets the brain's master clock and suppresses daytime melatonin, establishing a countdown for deep night sleep. Present-day indoor living cannot recreate these essential biological cues; modern workplace and school schedules further misalign natural rhythms, leading people to fall asleep at 4 a.m. and wake at noon, out of sync with societal demands.
Gominak notes that the COVID-19 pandemic intensified these problems as lockdowns forced populations indoors, amplifying vitamin D deficiency and sleep disturbances. Bartlett points to ...
Indoor Lifestyles and Sunlight Deprivation as Sleep Epidemic Causes
The Right Sleep Protocol is an individualized program that uses blood-based biochemistry to identify and correct vitamin D and B deficiencies in order to restore healthy sleep. Dr. Stasha Gominak emphasizes that protocol effectiveness relies on personalizing supplementation according to precise blood levels, tracking responses, and transitioning to the body’s natural systems for nutritional support as quickly as possible.
The protocol begins with baseline blood tests for vitamin D and B12. Dr. Gominak notes that hormones, including vitamin D, must be dosed based on measured blood levels, as both excessive and insufficient levels are problematic. Each person’s supplementation must be customized; for example, some individuals require far more vitamin D than others to maintain therapeutic levels. Practitioners should target vitamin D concentrations between 60-100 nanograms per milliliter for optimal results.
Vitamin D dosages are adjusted each month based on measured blood levels, recognizing that requirements vary widely, from 10,000 up to 30,000 IUs daily for some, depending on how their bodies metabolize and use the vitamin. Patients check their vitamin D status monthly, with ongoing adjustments to keep levels consistently optimal.
The initial phase involves correcting vitamin D and B12 deficiencies. If B12 is low, a separate supplement is added. After three months, if indicated, a B-complex supplement (often “B50” or “B100”) is introduced to address possible B vitamin depletion. Patients continue with vitamin D and B-complex for three to four months. Once sleep improves, they wean off high-dose B vitamins and transition to a multivitamin. This stages the return of nutrients provided by the healthy microbiome.
Clinical experience revealed that healthy sleep often returned with vitamin D supplementation alone, but after extended use, patients sometimes presented with new symptoms attributable to B vitamin deficiency.
This pattern was observed repeatedly: initial improvement on vitamin D, followed months or years later by symptoms like neuropathy, agitation, or sleep disruption, resolving with the addition of a B-complex. This highlights that vitamin D supplementation alone does not restore the gut microbiome or natural B vitamin production.
Adding a B-complex resolved these new symptoms and further improved sleep quality, confirming the essential role of B vitamins in sleep restoration alongside vitamin D.
After three to four months, high-dose B-complex supplements should be discontinued as elevated blood levels suppress the microbiome’s production of B vitamins. Excess supplementation risks symptoms like agitation and insomnia, especially when using high doses such as 400 mg of B5 (pantothenic acid).
Patients often report that over-supplementation causes pronounced negative effects—restlessness, worsened sleep, or anxiety—demonstrating the necessity of titrating down B vitamins in a timely fashion.
After B-complex supplementation is stopped, a balanced multivitamin offers minimal B vitamin support while the body’s restored microbiome resumes its natural B vitamin synthesis. This prevents deficiency but avoids suppressing endogenous production.
Right Sleep Protocol: Personalized Vitamin Supplements Based On Biochemistry
Current approaches in sleep medicine primarily focus on environmental and behavioral interventions, such as using blackout curtains, adhering to strict bedtimes, and controlling external stimuli. Stasha Gominak observes that these recommendations are based on the assumption that sleep disorders are psychological or stimulus-related. However, they prove ineffective for individuals whose disorders are driven by underlying biochemical imbalances, particularly vitamin D and microbiome deficiencies.
Gominak emphasizes that such individuals have already exhausted behavioral techniques before seeking specialized care. She explains that when the brain is deficient in vital nutrients like vitamin D, it “forgets how to sleep.” For these patients, traditional behavioral solutions cannot compensate for specific biochemical deficits, such as the absence of acetylcholine resulting from vitamin D deficiency. Instead, a specialized sleep treatment rooted in brain chemistry is needed for biochemically-driven disorders—a model not currently embraced in most of sleep medicine.
Sleep studies commonly focus on diagnosing and treating sleep apnea, primarily managed by pulmonologists and sleep doctors. However, Gominak’s experience shows that many patients, especially women with chronic daily headaches and fragmented sleep, do not meet the criteria for sleep apnea despite having severe sleep disturbances. These patients often experience abnormal, delayed, or absent REM sleep, which is not classified as sleep apnea by conventional standards, leaving them without proper diagnosis or effective treatment.
Gominak notes that CPAP machines, while providing temporary relief in cases of sleep apnea, do not address the biochemical roots of sleep disorders when parasympathetic dysfunction or vitamin deficiencies are involved. As a result, patients with significant REM-related abnormalities remain untreated within the current paradigm.
The dominant pharmaceutical approach in sleep medicine centers on symptom management rather than addressing core deficiencies. Antidepressants and sleeping pills are prescribed to induce unconsciousness, but they do not restore normal REM sleep or maintain parasympathetic dominance during the second half of the night—both critical for true restorative sleep.
While such medications may increase total sleep time, patients frequently remain fatigued, experience cognitive decline, and continue to have pain during the day. The ongoing prescription of psychiatric medications for sleep disorders ignores emerging ...
Why Sleep Medicine and Behavioral Interventions Fail to Address Causes
Download the Shortform Chrome extension for your browser
